Biogen Inc (BIIB)
153.68
+0.41
(+0.27%)
USD |
NASDAQ |
Jan 07, 14:48
Biogen Research and Development Expense (TTM): 2.080B for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
Eli Lilly and Co | 10.53B |
Pfizer Inc | 10.60B |
Amgen Inc | 5.774B |
Merck & Co Inc | 22.98B |
Moderna Inc | 4.827B |